Eculizumab Salvage Therapy for Antibody‐Mediated Rejection in a Desensitization‐Resistant Intestinal Re‐Transplant Patient

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-6143|15|7|1995-2000

ISSN： 1600-6135

Source： AMERICAN JOURNAL OF TRANSPLANTATION, Vol.15, Iss.7, 2015-07, pp. : 1995-2000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A refractory case of subclinical antibody‐mediated rejection due to anti‐HLA‐DQ antibody in a kidney transplant patient

By  

NEPHROLOGY, Vol. 20, Iss. S2, 2015-07 ,pp. : 81-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Progressive Multifocal Leukoencephalopathy in a Heart Transplant Recipient Following Rituximab Therapy for Antibody‐Mediated Rejection

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 4, 2013-04 ,pp. : 1075-1079

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody‐mediated rejection: a pilot study

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 5, 2015-05 ,pp. : 439-446

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of antibody‐mediated rejection in renal transplant patients: a clinical practice survey

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 2, 2015-02 ,pp. : 118-123

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibody‐mediated rejection in hand transplantation

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 27, Iss. 2, 2014-02 ,pp. : e13-e17

John Wiley & Sons Inc

Access to resources Recommend Favorite